Virologist Voznesensky: universal antibody 35B5 is not applicable as a vaccine 
Monoclonal antibody 35B5 to coronavirus, which was not applicable to Chinese scientists vaccine quality. Sergei Voznesensky, associate professor of the Department of Infectious Diseases of the RUDN University, said this in an interview with RBC.
The virologist explained that the antibody, which, according to Chinese researchers, is universal for use against all strains of infection, is a means for treating patients in the early stages … He said that most often such drugs are prescribed in infectious forms. “If a virus enters the human body, taking a monoclonal preparation of neutralizing antibodies will neutralize the viral particles, they will not cause disease,” Voznesensky emphasized.
Previously, Professor of Virology, Chief Researcher of the Gamaleya Research Center for Epidemiology and Microbiology Anatoly Altshtein also doubted that a universal vaccine against COVID-19 could be created on the basis of a monoclonal antibody discovered in China.
Prior to that, there was information that Chinese scientists obtained from the blood of a person who had been ill with COVID-19 in severe form, monoclonal antibody 35B5, which is supposedly capable of neutralizing various strains of COVID-19 and can serve as the basis for the development of a universal vaccine.